Cargando…
Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury
Cisplatin is a chemotherapy agent commonly used to treat a wide variety of cancers. Despite the potential for both severe acute and chronic side effects, it remains a preferred therapeutic option for many malignancies due to its potent anti-tumor activity. Common cisplatin-associated side-effects in...
Autores principales: | Mapuskar, Kranti A., Steinbach, Emily J., Zaher, Amira, Riley, Dennis P., Beardsley, Robert A., Keene, Jeffery L., Holmlund, Jon T., Anderson, Carryn M., Zepeda-Orozco, Diana, Buatti, John M., Spitz, Douglas R., Allen, Bryan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469643/ https://www.ncbi.nlm.nih.gov/pubmed/34572961 http://dx.doi.org/10.3390/antiox10091329 |
Ejemplares similares
-
Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease
por: Mapuskar, Kranti A., et al.
Publicado: (2018) -
Redox Regulation of Nrf2 in Cisplatin-Induced Kidney Injury
por: Mapuskar, Kranti A., et al.
Publicado: (2023) -
Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H(2)O(2)-Dependent Manner
por: Heer, Collin D., et al.
Publicado: (2018) -
Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism
por: Allen, Bryan G., et al.
Publicado: (2014) -
Superoxide Dismutases
and Superoxide Reductases
por: Sheng, Yuewei, et al.
Publicado: (2014)